Tujielimishe kidogo: Upimaji wa Corona Virus kupitia kwenye "damu"...

Retired

JF-Expert Member
Jul 22, 2016
40,173
73,616
EDI™ Novel Coronavirus COVID-19 ELISA Kits
Enzyme Linked Immunosorbent Assays (ELISA) for the qualitative detection of the COVID-19 IgG and IgM in human serum.


Overview


The 2019 Novel Coronavirus (COVID-19) is a single-stranded RNA coronavirus. Comparisons of the genetic sequences of this virus have shown similarities to SARS-CoV and other bat coronaviruses. In humans, coronaviruses cause respiratory infections. Coronaviruses are composed of several proteins including the spike (S), envelope (E), membrane (M), and nucleocapsid (N). It has been suggested that the spike protein has sufficient affinity to the angiotensin converting enzyme 2 (ACE2) receptor to use it as a mechanism of cell entry. Human-to-human transmission of coronaviruses is primarily thought to occur among close contacts via respiratory droplets generated by sneezing and coughing. There are over 90,000 (itakuwa imebadilika kwa leo) confirmed Coronavirus cases globally with over 3,000 (itakuwa imebadilika kwa leo) deaths as a direct result of the infection.

Effective detection of the coronavirus is extremely critical. Currently, real-time polymerase chain reaction (RT-PCR) tests detect genetic material to perform coronavirus testing. However, these tests have low rates of specificity and sensitivity and pose risks related to specimen collection and sample handling. Epitope Diagnostics, Inc. has developed a solution to minimize these risks by using IgG and IgM ELISA kits. IgG is the most abundant immunoglobulin to be produced in response to an antigen and is maintained in the body after initial exposure for long term response. IgM is the first immunoglobulin to be produced in response to an antigen and is primarily detected during the early onset of disease.




1585448432026.png
 
Kichwa ni kiswahili na mwili ni kingereza, huu uzi umeuchubua kwa vipodozi vilivyopigwa marufuku (umekopi).
Ilitakiwa uulete kwa lugha yetu,
 
0 Reactions
Reply
Back
Top Bottom